Supply Issues Danone Nutricia Ltd (Medical) Infant Drink ABT740 (ICN 3237)

• The supply issue with Infant Drinks from Danone Nutricia Ltd is continuing.
• The affected product remains subject to Protect Demand Management:
  • ABT740 – Infant Drinks 90ml sterilised.
• One product remains affected in total.
• ABT740 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• There are currently no identified alternative products available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 31 March 2026.

• The supply issue with Infant Drinks from Danone Nutricia Ltd is continuing.
• The affected product is no longer subject to Protect Demand Management and is now subject to intermittent supply:
  • ABT740 – Infant Drinks 90ml sterilised.
• One product remains affected in total.
• There are currently no identified alternative products available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 2 March 2026.

• The supply issue with Infant Drinks from Danone Nutricia Ltd is continuing.
• The affected product code remains subject to Protect Demand Management:
  • ABT740 – Infant Drinks 90ml sterilised.
• One product code is affected in total.
• ABT740 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• There are currently no identified alternative products available to order through our online catalogue.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 16 February 2026.

Change:

• The supplier Danone Nutricia Ltd (Medical) has informed us of a supply issue with its Infant Drink product.
• One product is affected:
  • ABT740 – Infant Drinks 90ml sterilised.
• The supply issue is due to increased demand and lead times.
• Due to this ongoing supply issue this product is now subject to Protect Demand Management.

Impact:

• The affected product is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• A potential indirect alternative product is available to order through our online catalogue:
  • ABT85006 – Infant Drinks Sterilised Water Suitable from birth Vegetarian.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives and for a full list of codes subject to Protect Demand Management.
• The supply issue is anticipated to be resolved by 16 February 2026.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.